Emmanuel B. Walter, MD, MPH
Department / Division
Pediatrics /
Pediatrics-Primary Care
Address
DUMC 3675
Durham, NC 27710
Appointment Telephone
919-620-5333
Office Telephone
919-620-5374
Fax Telephone
919-471-3820
- MD, University of Maryland School of Medicine, 1983
- Pediatrics, University of Maryland Medical Center, 1983-1986
- Pediatric Infectious Diseases, Duke University Medical Center, 1987-1990
- MPH, University of North Carolina at Chapel Hill, 1992
Clinical Interests
General pediatrics, childhood and adult immunizations
Research Interests
Dr. Emmanuel (Chip) B. Walter is Director of the Duke Translational Medicine Institute Clinical Vaccine Unit and he is Associate Director of the Primary Care Research Consortium at the Duke Clinical Research Institute.
Vaccine research:
Clinical Trials (vaccines for biodefense, pandemic and seasonal influenza virus vaccines, investigational respiratory virus vaccines, rotavirus vaccine, human papilloma virus vaccine, conjugate pneumococcal vaccine, conjugate meningococcal vaccines, combination vaccines)
Vaccine utilization (influenza vaccination of special populations, adolescent immunization)
Epidemiologic studies:
National Children's Study
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Merck Vaccine Division
- Novartis
- Sanofi Pasteur
Representative Publications
Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B, Walter EB. The HPV vaccine: are dosing recommendations being followed? Vaccine. 2011 Mar 21;29(14):2548-54.
(2011)
Abstract
Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD, . Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J. 2010 Feb;29(2):105-10.
(2010)
Abstract
Mast TC, Walter EB, Bulotsky M, Khawaja SS, DiStefano DJ, Sandquist MK, Straus WL, Staat MA. Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J. 2010 Feb;29(2):e19-25.
(2010)
Abstract
Walter EB, Allred NJ, Swamy GK, Hellkamp AS, Dolor RJ. Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates. Infect Control Hosp Epidemiol. 2010 Oct;31(10):1070-3.
(2010)
Abstract
Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? Vaccine. 2010 Jun 17;28(27):4376-83.
(2010)
Abstract
Mast TC, Demuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family. BMC Pediatr. 2009 Feb 6;9(1):11.
(2009)
Abstract
Walter EB, Allred N, Rowe-West B, Chmielewski K, Kretsinger K, Dolor RJ. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr. 2009 Sep-Oct;9(5):344-7.
(2009)
Abstract
Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD, . Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Pediatr Infect Dis J. 2009 Dec;28(12):1099-104.
(2009)
Abstract
Keitel WA, Campbell JD, Treanor JJ, Walter EB, Patel SM, He F, Noah DL, Hill H. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis. 2008 Nov 1;198(9):1309-16.
(2008)
Abstract
Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008 Jul 29;26(32):4057-61.
(2008)
Abstract
Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics. 2006 Sep;118(3):e579-85.
(2006)
Abstract
Guerra FA, Gress J, Werzberger A, Reisinger K, Walter E, Lakkis H, Grosso AD, Welebob C, Kuter BJ, . Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Pediatr Infect Dis J. 2006 Oct;25(10):912-9.
(2006)
Abstract
Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Pediatrics. 2006 Sep;118(3):e570-8.
(2006)
Abstract
Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005 Apr;115(4):1039-47.
(2005)
Abstract
Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan M, Heaton P. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J. 2003 Oct;22(10):914-20.
(2003)
Abstract
Clements DA, Zaref JI, Bland CL, Walter EB, Coplan PM. Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med. 2001 Apr;155(4):455-61.
(2001)
Abstract
Royce RA, Walter EB, Fernandez MI, Wilson TE, Ickovics JR, Simonds RJ, . Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health. 2001 May;91(5):727-33.
(2001)
Abstract
Walter EB, Royce RA, Fernández MI, DeHovitz J, Ickovics JR, Lampe MA, . New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstet Gynecol. 2001 Jan;97(1):70-6.
(2001)
Abstract
Fernández MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep. 2000 Sep-Oct;115(5):460-8.
(2000)
Abstract
Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatr Infect Dis J. 1999 Dec;18(12):1047-50.
(1999)
Abstract
Walter EB, Hornick RB, Poland GA, Tucker R, Bland CL, Clements DA, Rhamstine CC, Jacobson RM, Brown L, Gress JO, Harris KE, Wiens BL, Nalin DR. Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults. Vaccine. 1999 Mar 17;17(11-12):1468-73.
(1999)
Abstract
Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, Wilfert CM. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Pediatr Infect Dis J. 1995 Oct;14(10):874-9.
(1995)
Abstract
Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995 Oct;149(10):1113-7.
(1995)
Abstract
